Samuel Rigilin, Krishnananda Kamath Kunjal, Abdul Raheem Thayyil, and Ramakrishna Shabaraya. 2022. “FDA Regulatory Implications for Co-Crystals and Recent Co-Crystal Patents”. International Journal of Drug Regulatory Affairs 10 (3), 10-18. https://doi.org/10.22270/ijdra.v10i3.541.